Infant Death Clinical Trials

5 recruiting

Infant Death Trials at a Glance

8 actively recruiting trials for infant death are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Boston, Baltimore, and Beira. Lead sponsors running infant death studies include University of Virginia, Johns Hopkins University, and Happiest Baby, Inc..

Browse infant death trials by phase

Treatments under study

About Infant Death Clinical Trials

Looking for clinical trials for Infant Death? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infant Death trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infant Death clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Support Via Online Social Networks to Promote Safe Infant Care Practices

BreastfeedingInfant DeathSudden Infant Death Syndrome Without Mention of Autopsy
University of Virginia3,000 enrolled1 locationNCT05767658
Recruiting
Not Applicable

Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record

Sudden Infant DeathSudden Unexplained Infant Death
Johns Hopkins University350 enrolled1 locationNCT05503771
Recruiting

The Happiest Baby, Inc. SNOO Postmarket Surveillance Study

Infant DeathSerious Injury
Happiest Baby, Inc.1,000 enrolled1 locationNCT06361303
Recruiting
Not Applicable

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries- PreTerm

PretermInfant Death
Nemours Children's Clinic800 enrolled9 locationsNCT06240715
Recruiting
Not Applicable

Get Social Media and Risk-Reduction Training

Infant DeathSudden Infant Death
University of Virginia10,000 enrolled1 locationNCT06618586
Recruiting
Not Applicable

Advanced Wireless Sensors for Neonatal Care in the Delivery Room

Newborn MorbidityNewborn AsphyxiaSudden Unexplained Infant Death+2 more
Guilherme Sant'Anna, MD600 enrolled7 locationsNCT06693817
Recruiting

Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome

Sudden Infant DeathSudden Unexplained Infant Death
Nantes University Hospital650 enrolled15 locationsNCT06244433
Recruiting

Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment

Vertical Human Immunodeficiency Virus TransmissionHIV Infection PediatricInfant Death+2 more
Michael Hoelscher6,000 enrolled2 locationsNCT06267508